Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Classifica tra le azioni #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Prezzo delle azioni
$0.16240909
Ultima sincronizzazione: 2025-03-04
Capitalizzazione di mercato
$35.68M
Variazione (1 giorno)
0.27%
Variazione (1 anno)
0.00%
Paese
CN
Scambia Dali Pharmaceuticalco.,Ltd (603963)

Categoria

Rapporto P/B per Dali Pharmaceuticalco.,Ltd (603963)
Rapporto P/B al August 2026 TTM: 0.69
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Dali Pharmaceuticalco.,Ltd, il rapporto P/B attuale (TTM) è 0.69. Alla fine del 2022, era pari a 7.15.
Storico del rapporto P/B per Dali Pharmaceuticalco.,Ltd da 2012 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.69 -90.07%
2023 6.94 -3.00%
2022 7.15 54.26%
2021 4.64 27.40%
2020 3.64 -10.88%
2019 4.08 16.91%
2018 3.49 -22.46%
2017 4.51 -29.63%
2016 6.40 36.88%
2015 4.68 39.56%
2014 3.35 -4.78%
2013 3.52 -35.78%
2012 5.48 0.00%
Rapporto P/B per aziende simili o concorrenti